Coccidial infection in immunosuppressed mice: Prophylaxis and treatment with dehydroepiandrosterone

Eastern Mediterranean Health Journal

Volumn 6, Issue 5-6, 2000, Pages 908-918

  Khalifa, A M ^a   Ibrahim, I R ^a   El Kerdany, E D ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOLOGICAL ADJUVANT; IMMUNOSUPPRESSIVE AGENT; PRASTERONE;

ANIMAL; ANIMAL PARASITOSIS; ARTICLE; BIOPSY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODEL; DRUG SCREENING; FECES; IMMUNE DEFICIENCY; IMMUNOLOGY; MOUSE; PARASITOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOPSY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYCLOPHOSPHAMIDE; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FECES; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MICE; TOXOPLASMOSIS, ANIMAL;

EID: 0034261545     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Fayer RLE, Ungur BLP. Cryptosporidium spp. and cryptosporidiosis. Microbiological reviews, 1986, 50:458-83.
2. Allegra CJ et al. Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate. Journal of clinical investigation, 1987, 79:478-82.
3. Markell EK, Voge M, John DT. Lumen dwelling protozoa. In: Markell EK, Voge M, John DT, eds. Medical parasitology, 7th ed. Philadelphia, WB Saunders Company, 1991:85-8.
4. Fayer R et al. Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. Journal of parasitology, 1989, 75:393-7.
5. Leport C et al. Treatment of central nervous system toxoplasmosis with pyrimethamine sulfadiazine combination in 35 patients with acquired immunodeficiency syndrome. Efficiency of long-term continuous therapy. American journal of medicine, 1988, 84:94-100.
6. Dannemann BR et al. Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clidamycin to primethamine plus sulfadiazine. Annals of internal medicine, 1992, 116:33-43.
7. Fernandez-Martin J et al. Pyrimethamine-clarithromycin combination for therapy of acute toxoplasmic encephalitis in a patient with AIDS. Antimicrobial agents and chemotherapy, 1991, 35: 2049-52.
8. Hagberg L, Palmertz B, Lindberg J. Doxycycline and pyrimethamine for toxoplasmic encephalitis. Scandinavian journal of infectious disease, 1993, 25: 157-60.
9. Martin CR. Endocrine physiology. New York, Oxford University Press, 1985.
10. Lucos JA et al. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white FI mice fed dehydroepiandrosterone. Journal of clinical investigation, 1985, 75:2091-3.
11. Loria RM et al. Protection against acute lethal viral infections with the native steroid dihydroepianderosterone (DHEA). Journal of medical virology, 1988, 26: 301-4.
12. Esparza J. Report of a WHO informal consultation on per clinical and clinical aspects of the use of immunomodulators in HIV infection. AIDS, 1990, 4:1-14.
13. Arrowood MJ, Sterling C. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopyenic Percoll gradients. Journal of parasitology, 1987, 73:314-9.
14. Huskinson MJ, Araujo FG, Remington JS. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. Journal of infectious disease, 1991, 164: 170-7.
15. Kim CW. Cryptosporidium spp. experimental infection in Syrian golden hamsters. Experimental parasitology, 1987, 63:243-6.
16. Rasmussen KR, Healey MC. Dehydroepiandrosterone-induced reduction of Cryptosporidium parvum infections in aged Syrian golden hamsters. Journal of parasitology, 1992, 78:554-7.
17. Araujo FG et al. In vitro and in vivo activities of the hydroxyraphthoguinone 566, C 80 against the cyst form of Toxoplasma gondii. Antimicrobial agents and chemotherapy, 1992, 36:326-30.
18. Kelley RO, Dekker RAF, Bluemink JG. Ligand-mediated osmium binding: its application in coating biological specimens for scanning electron microscopy. Journal of ultrastructure research, 1972, 45:254-8.
19. Griffiths G. Fixation for fine structure preservation and immunocytochemistry. In: Griffiths G, ed. Fine structure immunocytochemistry. New York, Springer-Verlag, 1993:26-89.
20. Rasmussen KR, Healey MC, Martin EG. Effects of dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. Journal of parasitology, 1993, 79:364-70.
21. Youssef MM et al. Aminosidine sulphate in experimental cryptosporidiosis. Journal of the Egyptian Society of Parasitology, 1994, 24:239-49.
22. Khalifa AM, Sharaf El-Din NA. Aminosidine sulphate in experimental cryptosporidiosis: scanning electron microscopic study of ileal mucosa of Swiss albino mice. Journal of the Medical Research Institute, 1994, 15:101-6.
23. Araujo FG et al. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. Antimicrobial agents and chemotherapy, 1992, 36:2454-7.
24. Kovacs JA et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immune deficiencies. Annals of internal medicine, 1984, 100:663-71.
25. Bird RG, Smith MD. Cryptosporidiosis in man. Parasite life cycle and fine structural pathology. Journal of pathology, 1980, 132:217-33.
26. Sherwood D et al. Experimental cryptosporidiosis in laboratory mice. Infection and immunity, 1982, 38:471-5.
27. Sarciron ME et al. Alternations of Toxoplasma gondii induced by 2,3-dideoxyinosine in vitro. Journal of parasitology, 1998, 84:1055-9.
28. Lindsay DS et al. Ultrastructural effects of diclazuril against Toxoplasma gondii and investigation of a diclazuril resistant mutant. Journal of parasitology, 1995, 81:459-66.
29. Casson PR et al. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. American journal of obstetrics and gynecology, 1993, 169: 1536-9.
30. Rao KV et al. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydro-epiandrosterone. Cancer research, 1999, 59:3084-9.
31. Blanchard DK et al. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin-2. Journal of immunology, 1987, 139:551-6.
32. Suzuki N, Suzuki T, Sakane T. Hormones and lupus: defective dehydro-epiandrosterone activity induces impaired interleukin-2 activity of T-lymphocytes in patients with systemic lupus erythromatosus. Annales de médecine interne, 1996, 147:248-52.
33. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo. II. Dehydro-epiandro-sterone is a natural enhancer of interleukin-2 synthesis by helper T cells. European journal of immunology, 1990, 20:793-802.
34. El-Nassery SF et al. Interleukin-2 in experimental toxoplasmosis scanning electron microscopic study. Egyptian journal of medical science, 1996, 17: 435-43.